Celdaz 500 Injection Substitute
Composition:
DACARBAZINE-500MG
Uses:
Treatment of Metastatic Malignant Melanoma and Hodgkin's Disease
Medicinal Benefits:
Celdaz 500 Injection contains Dacarbazine, which belongs to the class of alkylating agents. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis. This helps prevent the growth and further spread of cancerous or non-cancerous cells.
Celdaz 500 Injection is used to treat Metastatic Malignant Melanoma and Hodgkin’s Disease.
Celdaz 500 Injection contains Dacarbazine, which belongs to the alkylating agents class. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis.
Celdaz 500 Injection may cause hemopoietic (bone marrow) depression, hepatic toxicity, and hepatic necrosis in some patients. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any side effects/interactions.
Celdaz 500 Injection is administered intravenously by a trained healthcare professional. Hence, do not self-administer.
Celdaz 500 Injection is not a potent vesicant. Celdaz 500 Injection is a chemotherapeutic medicine used in the treatment of skin cancer.
Celdaz 500 Injection works by inhibiting the DNA and RNA transcription that is essential for protein synthesis. This helps prevent the growth and further spread of cancerous or non-cancerous cells.
Celdaz 500 Injection may cause hair loss. Tell your doctor if it is severe or does not go away.
The common side effects of Celdaz 500 Injection may include nausea, vomiting, headache, dizziness, and pain at the site of injection. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.